Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome
Open Access
- 4 December 2019
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 17 (1) , 1-11
Abstract
Background: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating condition characterised by fatigue and post-exertional malaise. Its pathogenesis is poorly understood. GDF15 is a circulating protein secreted by cells in response to a variety of stressors. The receptor for GDF15 is expressed in the brain, where its activation results in a range of responses. Among the conditions in which circulating GDF15 levels are highly elevated are mitochondrial disorders, where early skeletal muscle fatigue is a key symptom. We hypothesised that GDF15 may represent a marker of cellular stress in ME/CFS. Methods: GDF15 was measured in serum from patients with ME/CFS (n = 150; 100 with mild/moderate and 50 with severe symptoms), “healthy volunteers” (n = 150) and a cohort of patients with multiple sclerosis (n = 50). Results: Circulating GDF15 remained stable in a subset of ME/CFS patients when sampled on two occasions ~ 7 months (IQR 6.7–8.8) apart, 720 pg/ml (95% CI 625–816) vs 670 pg/ml (95% CI 598–796), P = 0.5. GDF15 levels were 491 pg/ml in controls (95% CI 429–553), 546 pg/ml (95% CI 478–614) in MS patients, 560 pg/ml (95% CI 502–617) in mild/moderate ME/CFS patients and 602 pg/ml (95% CI 531–674) in severely affected ME/CFS patients. Accounting for potential confounders, severely affected ME/CFS patients had GDF15 concentrations that were significantly increased compared to healthy controls (P = 0.01). GDF15 levels were positively correlated (P = 0.026) with fatigue scores in ME/CFS. Conclusions: Severe ME/CFS is associated with increased levels of GDF15, a circulating biomarker of cellular stress that appears which stable over several months.Keywords
Funding Information
- Wellcome Trust (WT 214274/Z/18/Z)
- Medical Research Council (MRC_MC_UU_12012.1)
- National Institute of Allergy and Infectious Diseases (R01AI103629)
- ME Association (PF8947_ME Association)
This publication has 38 references indexed in Scilit:
- The prevalence of chronic fatigue syndrome/ myalgic encephalomyelitis: a meta-analysisClinical Epidemiology, 2013
- TGF-b Superfamily Cytokine MIC-1/GDF15 Is a Physiological Appetite and Body Weight RegulatorPLOS ONE, 2013
- Macrophage Inhibitory Cytokine 1 (MIC-1/GDF15) Decreases Food Intake, Body Weight and Improves Glucose Tolerance in Mice on Normal & Obesogenic DietsPLOS ONE, 2012
- Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary careBMC Medicine, 2011
- Specific correlations between muscle oxidative stress and chronic fatigue syndrome: a working hypothesisJournal of Muscle Research and Cell Motility, 2007
- Myalgic Encephalomyelitis/Chronic Fatigue SyndromeJournal of Chronic Fatigue Syndrome, 2003
- MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamilyProceedings of the National Academy of Sciences, 1997
- The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and StudyAnnals of Internal Medicine, 1994
- The Fatigue Severity ScaleArchives of Neurology, 1989
- MEASUREMENT OF PAINThe Lancet, 1974